MDK and neoplasm: Additionally, the MDK-NCL pathway suppresses cytotoxic immunity by reducing activated and effector memory CD8+ T cells while promoting an immunosuppressive microenvironment through increased Tregs and altering helper T cell differentiation, facilitating tumor immune evasion.